Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Julius

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JCI Insight|September 22, 2017
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responsesAaron Prodeus, Aws Abdul-Wahid, Amanda Sparkes, et al.
Infection Control and Hospital Epidemiology|July 9, 2015
Relationships among cleaning, environmental DNA, and healthcare-associated infections in a new evidence-based design hospitalEmil Lesho, Philip Carling, Eve Hosford, et al.
Plos One|May 20, 2016
The Challenges of Implementing Next Generation Sequencing Across a Large Healthcare System, and the Molecular Epidemiology and Antibiotic Susceptibilities of Carbapenemase-Producing Bacteria in the Healthcare System of the U.S. Department of DefenseEmil Lesho, Robert Clifford, Fatma Onmus-Leone, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
A Diverse Panel of Clinical Acinetobacter baumannii for Research and DevelopmentMadeline R Galac, Erik Snesrud, Francois Lebreton, et al.
Jac-Antimicrobial Resistance|December 15, 2021
A panel of diverse <i>Pseudomonas aeruginosa</i> clinical isolates for research and developmentFrancois Lebreton, Erik Snesrud, Lindsey Hall, et al.
Microbial Genomics|May 4, 2023
A panel of diverse <i>Klebsiella pneumoniae</i> clinical isolates for research and developmentMelissa J Martin, William Stribling, Ana C Ong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JCI Insight|September 22, 2017
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responsesAaron Prodeus, Aws Abdul-Wahid, Amanda Sparkes, et al.
Infection Control and Hospital Epidemiology|July 9, 2015
Relationships among cleaning, environmental DNA, and healthcare-associated infections in a new evidence-based design hospitalEmil Lesho, Philip Carling, Eve Hosford, et al.
Plos One|May 20, 2016
The Challenges of Implementing Next Generation Sequencing Across a Large Healthcare System, and the Molecular Epidemiology and Antibiotic Susceptibilities of Carbapenemase-Producing Bacteria in the Healthcare System of the U.S. Department of DefenseEmil Lesho, Robert Clifford, Fatma Onmus-Leone, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2020
A Diverse Panel of Clinical Acinetobacter baumannii for Research and DevelopmentMadeline R Galac, Erik Snesrud, Francois Lebreton, et al.
Jac-Antimicrobial Resistance|December 15, 2021
A panel of diverse <i>Pseudomonas aeruginosa</i> clinical isolates for research and developmentFrancois Lebreton, Erik Snesrud, Lindsey Hall, et al.
Microbial Genomics|May 4, 2023
A panel of diverse <i>Klebsiella pneumoniae</i> clinical isolates for research and developmentMelissa J Martin, William Stribling, Ana C Ong, et al.
Pageof 2